Precision Optics Corporation, Inc. (POCI) Stock Price & Analysis
Precision Optics Corporation, Inc. (POCI) rose 0.00% to USD 4.3 as of July 26, 2026 at 01:27 UTC, according to Nexqual real-time market data.
POCI last closed at USD 4.3; the session ranged USD 4.24–4.44 on volume of 24,400 shares. Market capitalization is $47.06M, with a 52-week range of USD 3.55–6.15 (NCM). Source: Nexqual, July 26, 2026 at 01:27 UTC.
Key Statistics (as of July 26, 2026 at 01:27 UTC)
| Price | USD 4.3 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 4.3 |
| Open | USD 4.37 |
| Day Range | USD 4.24 – 4.44 |
| 52-Week Range | USD 3.55 – 6.15 |
| Volume | 24,400 shares |
| Market Cap | $47.06M |
| Exchange | NCM |
Technical Analysis (POCI)
Nexqual's technical model rates POCI "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 01:27 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 28.78 (oversold) |
| vs SMA50 | Below (USD 5.13) |
| MACD | -0.24 (negative) |
Analyst Ratings (POCI)
Wall Street analysts rate POCI "None" based on 1 analysts, with a mean price target of USD 8 (range USD 8–8), per Nexqual as of July 26, 2026 at 01:27 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 8 |
| High Target | USD 8 |
| Low Target | USD 8 |
| Buy / Hold / Sell | 1 / 0 / 0 |
Earnings (POCI)
| Next Earnings Date | 2026-09-28 |
|---|---|
| EPS Estimate | USD -0.06 |
| Revenue Estimate | $7.15M |
Source: Nexqual, July 26, 2026 at 01:27 UTC.
Financials & Fundamentals (POCI)
| Total Revenue | $28.94M |
|---|---|
| Revenue Growth (YoY) | +108.00% |
| Gross Margin | +13.85% |
| Operating Margin | -0.74% |
| Profit Margin | -17.03% |
| ROE | -29.62% |
| Debt / Equity | 21.29 |
| Current Ratio | 2.1 |
| Total Cash | $10.68M |
| Total Debt | $4.28M |
| Free Cash Flow | $-249,888 |
Source: Nexqual, July 26, 2026 at 01:27 UTC.
Financial Health Score (POCI)
Nexqual rates Precision Optics Corporation, Inc.'s overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 01:27 UTC.
| Growth | Strong — Revenue +108% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Strong — $11M cash vs $4M debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$1M |
| Efficiency | Critical — ROE -30%, ROA -11.2% |
Ownership (POCI)
| Insider Ownership | +20.98% |
|---|---|
| Institutional Ownership | +43.51% |
| Shares Outstanding | 10.94M |
| Float | 8.13M |
| Short % of Float | +0.25% |
Source: Nexqual, July 26, 2026 at 01:27 UTC.
Leadership (POCI)
Precision Optics Corporation, Inc. is led by Joseph N. Forkey (age 57), CEO, President, Treasurer & Director, per Nexqual as of July 26, 2026 at 01:27 UTC.
| CEO, President, Treasurer & Director | Joseph N. Forkey (age 57) |
|---|---|
| CFO, Principal Accounting Officer & Secretary | Wayne M. Coll (age 61) |
| Founder, Advisor to the CEO & Director Emeritus | Richard E. Forkey (age 85) |
| Chief Operating Officer | Joseph Traut (age 53) |
| Vice President of Sales & Marketing | Clay Schwabe |
Major Backers & Investors (POCI)
Notable institutional backers of Precision Optics Corporation, Inc. include Needham Investment Management, L.L.C., Needham Funds Inc-Needham Aggressive Growth Fund, MYDA Advisors LLC, according to Nexqual as of July 26, 2026 at 01:27 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Needham Investment Management, L.L.C. | 29.63% |
| Needham Funds Inc-Needham Aggressive Growth Fund | 29.63% |
| MYDA Advisors LLC | 7.09% |
| Nantahala Capital Management, LLC | 4.97% |
| Bleichroeder LP | 4.81% |
| Wealthtrust Axiom, LLC | 4.51% |
| Archon Capital Management LLC | 2.78% |
| Morgan Stanley | 2.55% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 6.88% |
Source: Nexqual, July 26, 2026 at 01:27 UTC.
From Precision Optics Corporation, Inc.'s Latest SEC 10-K Filing (filed 2025-09-29)
Key Strengths & Strategy (as disclosed to the SEC)
- Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.
- The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians.
- It also provides components and assemblies for industrial and military use.
- It markets its products to medical device companies.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FBCE | FIBERCORE INC | USD 0 | ▲ 0% |
| NEWP | New Pacific Metals Corp. | USD 4.5 | ▼ 3.85% |
| OPTX | Syntec Optics Holdings, Inc. | USD 7.05 | ▼ 15.16% |
| PIII | P3 Health Partners Inc. | USD 9.62 | ▼ 2.43% |
| ETEK | Eco-Tek Group, Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 01:27 UTC. This page is informational and not investment advice.